AUDIATMED
ActiveSummary
AUDIATMED has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €250,067 and a net result of €142,991. Equity is growing by about 103% per year across the filed financial years. Its solvency ranks better than 68% of 20,614 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
History
On 26 July 2023, AUDIATMED was incorporated as a private limited company by one natural person, with a starting capital of €2,500.12 In 2026 the registered office moved to Saint-Gilles.3 AUDIAT Charles Jean Jacques has served as director of the company since 2023.2 Total assets went from €38,180 in 2023 to €319,343 in 2025.4
Acts, filings and financial milestones
10-04
Gazette deed
Registered officeRegistered-office move · Director in office3 facts ▸
- Board meeting, 25-09-2025
- Registered-office move, Rue Antoine Breart 54 à 1060 SAINT-GILLES
- Director in office, Charles AUDIAT (director)
31-07
Gazette deed
IncorporationAppointment: AUDIAT Charles Jean Jacques (director) · Permanent representative: AUDIAT Charles Jean Jacques · Registered office clause10 facts ▸
- Registered office clause, “1060 Saint-Gilles,Rue Egide Walschaerts 22 /TM” (deed in French)
- Board rule, 1
- Director appointment, AUDIAT Charles Jean Jacques (director (not named in the articles))
- Permanent representative, AUDIAT Charles Jean Jacques (permanent)
- Pre-incorporation commitments, “takeover, tous engagements obligations activités entreprises au nom et pour compte société en formation” (deed in French)
- Other provision, “mentions dépôt” (deed in French)
- Incorporation, “AUDIATMED” (deed in French)
- Founder, AUDIAT Charles Jean Jacques (comparant fondateur)
- Founding capital, €2,500
- Bank account, 2500, EUR